December 2025
The global uterine fibroid drugs market size is evaluated at USD 3.16 billion in 2025 and is predicted to hit around USD 11.93 billion by 2035, growing at a CAGR of 14.21%.
December 2025
The oncology/cancer drugs market size is calculated at USD 192.39 billion in 2025 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
December 2025
The antihypertensive drugs market size is valued at USD 25.50 billion in 2025 and is expected to be worth around USD 35.99 billion by 2034 with a CAGR of 3.90%.
December 2025
The global insulin drugs and delivery devices market size is evaluated at USD 25.53 billion in 2025 and is predicted to hit around USD 49.39 billion by 2034, growing at a CAGR of 7.61%.
November 2025
The global atherosclerosis drugs market size is projected to hit around USD 24.25 billion by 2034, increasing from USD 17.60 billion in 2025, with a CAGR of 3.63%.
November 2025
The global duchenne muscular dystrophy drugs market size is projected to hit around USD 19.46 billion by 2034, increasing from USD 4.79 billion in 2025, with a CAGR of 16.85%.
November 2025
The global epigenetic drugs market size is anticipated at USD 16.22 billion in 2025 and is predicted to hit around USD 80.81 billion by 2034, growing at a CAGR of 19.53%.
November 2025
The U.S. pain management drugs market size is calculated at USD 32.79 billion in 2025 and is predicted to increase from USD 33.84 billion in 2026 to approximately USD 44.90 billion by 2034, expanding at a CAGR of 3.60% from 2025 to 2034.
November 2025
November 2025
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 17.15 billion by 2034 increasing from USD 8.44 billion in 2025, with a CAGR of 8.18%.
November 2025
The global hyperlipidemia drugs market size is calculated at USD 23.85 billion in 2025 and is projected to surpass USD 33.94 billion by 2034 with a CAGR of 4%.
November 2025
The global DNA repair drugs market size reached USD 9.36 billion in 2025 and is predicted to surpass around USD 30.28 billion by 2034 with a notable CAGR of 13.98%.
November 2025
The U.S. over the counter (OTC) drugs market size is estimated at USD 24.81 billion in 2025 and is predicted to increase from USD 26.00 billion in 2026 to approximately USD 44.17 billion by 2034, expanding at a CAGR of 6.60% from 2025 to 2034.
November 2025
The global cardiovascular drugs market size is calculated at USD 155.96 billion in 2025 and is predicted to increase from USD 162.02 billion in 2026 to approximately USD 214.72 billion by 2034, expanding at a CAGR of 3.62% from 2025 to 2034.
October 2025
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
October 2025
The global contraceptive drugs market size is valued at USD 19.00 billion in 2025 and is expected to hit around USD 31.60 billion by 2034, at a CAGR of 5.82%.
October 2025
The global over the counter (OTC) drugs market size was valued at USD 135.25 billion in 2025 and is expected to hit around USD 242.94 billion by 2034, growing at a CAGR of 6.72%.
October 2025
The global critical care drugs market size was evaluated at USD 1.22 billion in 2025 and is projected to surge around USD 1.91 billion by 2034, with a CAGR of 5.11%.
October 2025
The global pain management drugs market size was calculated at USD 87.19 billion in 2025 and is predicted to increase from USD 90.50 billion in 2026 to approximately USD 125.68 billion by 2034, expanding at a CAGR of 4.10% from 2025 to 2034.
October 2025
The global antifungal drugs market size was exhibited at USD 18.00 billion in 2025 and is projected to hit around USD 24.51 billion by 2034 with a CAGR of 3.49%.
August 2025
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
August 2025
The global pulmonary alveolar proteinosis (PAP) drugs market size was evaluated at USD 750.05 million in 2024 and is predicted to hit around USD 1,478.22 million by 2034, growing at a CAGR of 7.02%.
August 2025
August 2025
The global general anesthesia drugs market size was calculated at USD 5.40 billion in 2024 and is projected to surpass around USD 7.79 billion by 2034, with a CAGR of 3.73%.
August 2025
The global rheumatoid arthritis drugs market size was valued at USD 63.22 billion in 2024 and is expected to hit around USD 75.53 billion by 2034, growing at a CAGR of 1.80% from 2025 to 2034.
August 2025
The global generic drugs market size was calculated at USD 445.62 billion in 2024 and is predicted to increase from USD 468.08 billion in 2025 to approximately USD 728.64 billion by 2034, expanding at a CAGR of 5.04% from 2025 to 2034.
August 2025
The global injectable cytotoxic drugs market size is estimated to hit around USD 35.71 billion by 2034 increasing from USD 19.48 billion in 2024, with a CAGR of 6.25%.
August 2025
The global deoxycholic acid obesity drugs market size is estimated to hit around USD 1,830.89 million by 2034 increasing from USD 486.14 million in 2024, with a CAGR of 14.18%.
July 2025
The global atrial fibrillation drugs market size was evaluated at USD 15.59 billion in 2024 and is projected to surpass around USD 20.99 billion by 2034, with a CAGR of 3.02%.
July 2025
The global anti-obesity drugs market size is estimated at USD 7.14 billion in 2025, and is projected to hit around USD 55.25 billion by 2034, with a CAGR of 5.53%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com